1. Home
  2. PCTY vs IBRX Comparison

PCTY vs IBRX Comparison

Compare PCTY & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paylocity Holding Corporation

PCTY

Paylocity Holding Corporation

SELL

Current Price

$184.63

Market Cap

9.3B

Sector

Technology

ML Signal

SELL

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

SELL

Current Price

$6.04

Market Cap

8.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PCTY
IBRX
Founded
1997
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
8.2B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
PCTY
IBRX
Price
$184.63
$6.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
4
Target Price
★ $196.25
$14.25
AVG Volume (30 Days)
640.1K
★ 12.5M
Earning Date
11-05-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
22.39
★ 38.71
EPS
★ 1.07
N/A
Revenue
★ $1,771,326,000.00
$113,288,000.00
Revenue This Year
$8.46
$99.98
Revenue Next Year
$7.38
$108.29
P/E Ratio
$166.76
★ N/A
Revenue Growth
11.04
★ 668.31
52 Week Low
$92.99
$1.95
52 Week High
$181.58
$12.43

Technical Indicators

Market Signals
Indicator
PCTY
IBRX
Relative Strength Index (RSI) 73.77 32.94
Support Level $162.66 N/A
Resistance Level N/A $8.62
Average True Range (ATR) 6.61 0.56
MACD 0.25 -0.26
Stochastic Oscillator 98.67 8.78

Price Performance

Historical Comparison
PCTY
IBRX

About PCTY Paylocity Holding Corporation

Paylocity is a cloud-based human capital management provider offering payroll, compliance, and human resources management solutions. With the addition of expense and IT management modules, Paylocity unifies back-office operations spanning HR, finance, and IT on a single platform and bills customers on a subscription basis. The firm's customer base skews toward the midmarket and is primarily based in the US. As of fiscal 2026, Paylocity has nearly 44,400 customers.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: